69656-102 : Varubi 1.8 mg/ml Intravenous Injection, Emulsion


NDC: 69656-102
Labeler: Tesaro, Inc.
Product Type: Human Prescription Drug
Drug Name:  Varubi
Dosage Form: Intravenous Injection, Emulsion
Application #: NDA208399
Rev. Date: 


NDC Package Codes:

  • 69656-102-10: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (69656‑102‑10) > 92.5 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Rolapitant

Dosage Strength:

  • 1.8 mg/mL

Pharmaceutical Classes:

  • Neurokinin 1 Antagonists [MoA]
  • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 69656-101 Varubi 90 mg Oral Tablet by Tesaro, Inc.
  • 70720-101 Varubi 90 mg Oral Tablet by Tersera Therapeutics LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69656-102 QR Code

< Prev: 69656-101Next: 69656-103 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.